The Uromigos: ASCO

Hear Thomas Powles, MD, and Brian Rini, MD, FASCO, discuss research and news from the ASCO annual meeting.

More News From ASCO 2023
Episode 242: ASCO 2023 - The THOR Study: Erdafitinib vs Chemotherapy in Bladder Cancer
Yohann Loriot, MD, PhD, discusses the practice-changing THOR study data on the survival benefit of erdafitinib for advanced urothelial carcinoma while at the American Society of Clinical Oncology 2023 Annual Meeting. Dr. Loriot is a physician scientist and director of the Université Paris-Saclay’s bladder cancer program. ...
Advertisement
Advertisement
Advertisement
Advertisement